|
|
|
|
|
|
 |
|
TIMOTHY J. WOLLAEGER
Chairman of the Board
Timothy J. Wollaeger has served as a member of our Board of Directors since April 1994 and as our Chairman since January 1996. Mr. Wollaeger has been the Managing Director for the San Diego office of Sanderling Biomedical Venture Capital, a venture capital investment company, since April 2002. He was the general partner of Kingsbury Associates, L.P., a venture capital firm he founded in January 1994 and which focused on investments in the healthcare industry until it dissolved in December 2006. From May 1990 to December 1993, Mr. Wollaeger served |
|
|
|
|
| as Senior Vice President and a director of Columbia Hospital Corporation, a hospital management company now known as HCA Healthcare Corporation. From October 1986 until July 1993, Mr. Wollaeger was a general partner of Biovest Partners, a seed venture capital firm. He is a member of the board of directors of Biosite, Inc., a medical diagnostic company, and a founder and director of several privately held medical products companies. Mr. Wollaeger received his B.A. in economics from Yale University and his M.B.A. from the Stanford University Graduate School of Business. |
|
|
|
|
|
 |
|
|
MARK L. CASNER
Director
Mark L. Casner has served as our President and Chief Executive Officer since January 2006 and as President of Digirad Imaging Solutions from October 2005 to January 2006. Prior to coming to Digirad, Mr. Casner served as President of DMS Imaging, a mobile imaging company, from 2003 to 2005. |
|
|
|
|
| From 1995 through 2003 he was a member of Radiologix, a radiology services company, and its predecessor organization, most recently as Senior Vice President of Operations. Mr. Casner received a B.A. from Miami University of Ohio, an M.A. from the University of Maryland and an M.B.A. from Marymount University. |
|
|
|
|
|
| |
|
|
GERHARD F. BURBACH
Director
Gerhard F. Burbach served as our President and Chief Executive from April 2005 to January 2006 and has served as a member of our Board of Directors since October 2004. He now serves as President and Chief Executive Officer of Thoratec Corporation, a manufacturer of medical devices used by patients with congestive heart failure. Before joining us as our President and Chief Executive Officer, Mr. Burbach served as President and Chief Executive Officer of Bacchus Vascular, a developer of catheter-based medical devices for the removal of blood clots. |
|
|
|
|
|
|
|
| Prior to that, he held the position of Chief Executive Officer of Phillips Nuclear Medicine, a division of Phillips Electronics, from January 2001 to July 2003 and, before its acquisition by Phillips, worked for four years for ADAC Laboratories, most recently as President and General Manager of its nuclear medicine division. Mr. Burbach received a B.S. in industrial engineering from Stanford University and an M.B.A. from Harvard Business School. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
